Gheuens Sarah

Insider·AGIOS PHARMACEUTICALS, INC.·AGIO·Insider since 2025·Form 4 filings: 11
Trades YTD
1
Trades (12m)
8
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

8 transactions
30 Dec 2025
SOLD
$AGIO
2,932
$27.09
S
11 Nov 2025
SOLD
$AGIO
2,454
$43.78
S
30 Oct 2025
SOLD
$AGIO
200
$43.81
S
27 Oct 2025
SOLD
$AGIO
3,302
$43.92
S
09 Jul 2025
SOLD
$AGIO
847
$38.76
S
09 Jul 2025
SOLD
$AGIO
11,067
$37.93
S
01 Jul 2025
SOLD
$AGIO
4,091
$34.17
S
24 Jun 2025
SOLD
$AGIO
2,909
$33.54
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · AGIOS PHARMACEUTICALS, INC.

last 30 days

No active insider cluster at AGIOS PHARMACEUTICALS, INC. in the last 30 days. Sarah's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Sarah is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 09:49 UTC.